echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Bilirubin is a stroke protection factor! Latest Analysis of CSPPT

    Bilirubin is a stroke protection factor! Latest Analysis of CSPPT

    • Last Update: 2020-06-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    Recently, an after-the-fact analysis of a Chinese stroke primary prevention trial (CSPPT) showed that in patients with hypertension, serum total bilirubin or direct bilirubin was associated with the risk of first ischemic stroke strokeStudies have shown that in patients with hypertension, the risk of stroke in the first ischemic stroke was reduced by 25% compared to those with the first serite serum bilirubin level (9.3 smol/L)The study also found that those with direct bilirubin trinograms (2.5 to 24.8 smol/L) also had a 23 percent lower risk of stroke for the first ischemic stroke than those with the first-level level (1.6 smol/L)Figure 1 Seroser total bilirubin or direct bilirubin was negatively associated with the risk of first ischemic stroke in hypertensive patients, however, no serotonin and direct bilirubin levels were found to be associated with first hemorrhagic strokeSerum bilirubin, an endogenous antioxidant, is positively correlated with the body's total antioxidant capacity, after previous studies have shown that its antioxidant activity is not related to its formIt has also been found that serum bilirubin is associated with oxidation of lipids and lipoproteins and endothelial damage, which in turn contributes to the formation of arterial porridge plaques and arterial thrombosisPrevious studies have also shown that people with type 2 diabetes have improved antioxidant and endothelial-dependent vascular diastolic abilities after applying the increased bilirubin drug AzanavirIf the study is further confirmed in the future, the researchers said, routine testing of bilirubin may help identify ischemic stroke in patients with high blood pressureThe study included 19906 patients with hypertension in the CSPPT trial, and 608 people had stroke during a median follow-up period of 4.5 years, including 489 ischemic strokes, 117 cases of hemorrhagic stroke, and 2 cases of ambiguous type strokeSource: Wang J, Zhang X, Zhang Z, et alBaseline Baseline Bilirubin and Risk of First in Strokeve Patients (public lyn online of the print, 2020 Jun 3)J Am Heart Assoc2020; e015799Author: Xi Xi Source: China Circulation Magazine
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.